RYTHM, Inc. (RYM): Nasdaq/NYSE listing notice — Agrify receives third Nasdaq delinquency notice for failure to file Q2 2023 10-Q

RYTHM, Inc.

Received August 16, 2023 Nasdaq notice for non-compliance with Listing Rule 5250(c)(1) due to late Q2 2023 Form 10-Q.
Previously granted exception until Sept 30, 2023 to file Form 10-K (FY2022) and Q1 2023 10-Q; Q2 filing is new delinquency.
Audit committee restated financials for Q1-Q3 2022 due to warrant accounting errors; ongoing filing delays.
No immediate delisting effect, but failure to regain compliance could lead to delisting.
Company working to file Q2 10-Q within prescribed period; must update compliance plan.

item 3.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

RYTHM, Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: late filing
Rules: 5250(c)(1)

Exact text from the filing

August 16, 2023, the Company received a third notice from Nasdaq that the Company remains noncompliant with the Nasdaq Listing Rule 5250(c)(1) as a result of its failure to file its Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2023 (the “Second Quarter Form 10-Q”) with the SEC by the required filing date (the “August Nasdaq Notice” and, together with the April Nasdaq Notice and the May Nasdaq Notice, the “Nasdaq Notices”). As disclosed in the Current Report on Form 8-K filed by the Company on April 17 , 2023, the Company’s audit committee concluded that, as a result of i

View on SEC.gov

Browse all listing & compliance notices →

RYTHM, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-23-069116

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.